The Novor team will once again attending the prestige PEGS Boston conference hosted at the Seaport World Trade Center in Boston, May 1 to 5, 2017.
With the successful completion of over 100 sequencing projects in the past 12 months, we are proud to share the experiences and best practices we have developed during our journey. Our co-founder, Mingjie, will give a talk on 12:30pm Monday about Antibody Protein De Novo Sequencing with LC-MS/MS. If you can’t make to the talk, no worries. Our team will be at booth #305 this whole week and we are more than happy to discuss with you on how we may help in your research.
Already have the antibody sequences but not 100% sure about PTMs, glycans or the sequences themselves? Talk to us and we may already have a solution for you.
Newsletter for All Things Protein Sequencing
Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics